• Kenyu Kamizato, Sho Sato, Subrata Kumar Shil, Banlanjo A Umaru, Yoshiteru Kagawa, Yui Yamamoto, Masaki Ogata, Yuki Yasumoto, Yuko Okuyama, Naoto Ishii, Yuji Owada, and Hirofumi Miyazaki.
• Department of Organ Anatomy, Tohoku University Graduate School of Medicine, Sendai, Japan.
• Neuroscience. 2019 Jun 15; 409: 120-129.

AbstractFatty acid binding protein 7 (FABP7) is expressed in astrocytes of the developing and mature central nervous system, and modulates astrocyte function by controlling intracellular fatty acid homeostasis. Astrocytes in the spinal cord have an important role in the process of myelin degeneration and regeneration. In the present study, the authors examined the role of FABP7 in astrocytes in a mouse model of experimental autoimmune encephalomyelitis (EAE), which is an established model of multiple sclerosis (MS). FABP7 was expressed in the white matter astrocytes and increased after EAE onset; particularly strong expression was observed in demyelinating regions. In FABP7-knockout (KO) mice, the onset of EAE symptoms occurred earlier than in wild type (WT) mice, and mRNA expression levels of inflammatory cytokines (IL-17 and TNF-α) were higher in FABP7-KO lumbar spinal cord than in WT lumbar spinal cord at early stage of EAE. Interestingly, however, the clinical score was significantly reduced in FABP7-KO mice compared with WT mice in the late phase of EAE. Moreover, the area exhibiting expression of fibronectin, which is an extracellular matrix protein mainly produced by astrocytes and inhibits remyelination of oligodendrocytes, was significantly decreased in FABP7-KO compared with WT mice. Collectively, FABP7 in astrocyte may have a role to protect from the induction of inflammation leading to demyelination in CNS at early phase of EAE. Moreover, FABP7 may be involved in the regulation of fibronectin production through the modification of astrocyte activation at late phase of EAE.Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

23 keywords...

hide…